Structuring sustainable MSD prevention in the workplace
A structured solution designed for organizations with 25 to several thousand employees, combining individualized functional assessment, anonymous collective management, and integration with regulatory requirements.
This system for preventing musculoskeletal disorders in the workplace is designed for organizations that want to go beyond one-off initiatives and make prevention a continuous and measurable part of their approach.
A structured solution, beyond an application
The prevention of musculoskeletal disorders in the workplace cannot rely solely on raising awareness or providing tools.
It requires a coherent link between individual action and collective interpretation. It involves assessing functional capacities, supporting their progress, and having indicators available to guide decisions over time.
The Neomove solution is based on:
a biomechanical assessment using the Move Test
a personalized program tailored to employees' actual abilities
a management environment for aggregating and analyzing field dynamics
The detailed functioning of the biomechanical device and the prevention control architecture are presented in the dedicated sections.
Prevention is not limited to encouragement.
It must be evaluated, structured, and managed.
Architecture tailored to structured organizations
The solution can be integrated gradually according to your level of prevention maturity and your internal organization.
Strengthen the functional capacity of teams
The foundation directly influences employees' ability to adapt to professional constraints.
Based on the Move Test, each employee benefits from a personalized program. Movement sessions, targeted protocols, and active breaks aim to maintain the abilities necessary for the sustainable absorption of workplace stress.
The goal is not only to reduce temporary discomfort, but to support long-term functional stability.
Structuring collective management
Beyond individual action, prevention makes sense when it can be analyzed collectively.
The enterprise CMS aggregates anonymized indicators and allows population trends to be identified. The data is strictly aggregated and cannot be accessed at an individual level.
They enable you to:
Guiding ergonomic decisions
Prioritizing certain populations
Objectify budgetary trade-offs
Update the DUERP and PAPRIPACT
The solution thus transforms individualized action into a collective lever for decision-making.
Supporting strategic integration
Depending on your objectives, additional modules can be deployed:
Customized launch webinar
Internal communication media
Multi-site support
Awareness and satisfaction surveys
Support is tailored to your architecture and your QVCT priorities.
Deploy a structured pilot
To implement the process in a concrete and measurable way, the Neomove solution can be rolled out as a structured pilot program.
The pilot program will run for a minimum of 60 days to allow for two successive evaluations and a reliable reading of developments.
It includes:
Scoping meeting and definition of objectives
Anonymous awareness questionnaire to establish a baseline
Customized launch webinar
Internal mobilization tailored to your organization
Regular follow-up points
Final analysis and validation report
The success of the pilot program depends on shared commitment.
The company mobilizes its teams; Neomove structures and supports the process.
The pilot program is fee-based and tax-deductible if implemented on a broader scale.
An investment with measurable impact
Structured occupational health prevention programs offer a positive return on investment when implemented over the long term.
According to the European Agency for Safety and Health at Work, every euro invested in occupational health prevention measures can generate an estimated return of between €2.5 and €4.8.
The prevention of MSDs produces measurable effects when individual action is continuous and data is used collectively.
It is not just a matter of reducing costs. It is a matter of controlling a structural risk.
$2.50 to $4.80
Estimated return per euro invested in prevention (EU-OSHA)
Investment and terms of engagement
For organizations wishing to integrate field action and collective management, the investment starts at €72 (excluding tax) per employee per year, with a sliding scale based on volume and multi-entity architecture.
This rate corresponds to a continuous system incorporating functional assessment, individualized progress, and organizational management.
No personal health data is accessible at the company level. Analyses are based exclusively on aggregated and anonymized data in accordance with GDPR requirements.
FAQ: Driver
-
The pilot program is registered for a minimum duration of 60 days to allow for two successive evaluations and a reliable analysis of developments.
-
Yes. The data is aggregated and inaccessible at an individual level.
-
Yes. The pilot amount is deducted in the event of generalization.
Assess the appropriateness of a pilot program
Before a global rollout, many companies choose to test Neomove through a structured pilot program.
This pilot program allows us to observe employee engagement, initial usage trends, and prevention indicators.
This exchange will enable us to analyze your context, define your objectives, and evaluate the integration process.